Pα+ Psychedelic Bulletin #156: Canada’s First Published Psilocybin Trial; University of Maryland Joins Terran’s Complaint Against Compass

Featured content in this Issue: This is the first issue of our Psychedelic Bulletin that’s exclusively for Pα+ subscribers. Head to our Join page to learn more, or sign in to your account.

Source

Farmworkers face high-risk exposures to bird flu, but testing isn’t reaching them

Farmworkers face some of the most intense exposures to the bird flu virus, but advocates say many of them would lack resources to fall back

May 29, 2024

FTC Sues Anesthesia Group and Its Private Equity Backers

For the first time in history, the Federal Trade Commission (FTC) has sued both a medical group and its private equity backers, alleging anticompetitive practices

September 27, 2023

Revive Therapeutics Ltd. Announces Offering of Up to $3 Million | Psychedelic Invest

REVIVE THERAPEUTICS LTD. (CSE: RVV; OTCQB: RVVTF) (“Revive” or the “Company”) announces that it is arranging a private placement of a maximum of 85,714,285 units

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.